Maxime Chénard-Poirier
Chercheur associé
Axe Oncologie
Publications
View all-
article Meric-Bernstam F, Gutierrez M, Sanz-Garcia E, Villa D, Zhang J, Friedmann J, Yan F, Socinski MA, Sarantopoulos J, Raez LE, Chu QS, Chénard-Poirier M, Chatterjee MS, Ren H, Liu Q, Levine DA, Jhaveri KL
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors
Cancer Res Commun 5 (9), 2025.
-
article Leclerc JF, Samson-Roy T, Chénard-Poirier M, Tremblay ML, Lafleur A
Print-It-Yourself Bone Marrow Biopsy Simulator Compared With Human Cadavers
Simul Healthc 20 (4), 2025.
-
article Pelland AA, Deschênes-Simard X, Savard X, Giguère P, Spillane D, Barabé F, Laroche V, Munger M, Gallagher G, Marcoux N, Cantin G, Chénard-Poirier M, Delage R, Lalancette M, Veilleux O, Assouline SE, Lemieux C
Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study
Leuk Lymphoma 65 (13), 2024.
Projects
- Rôle de l'immunothérapie en néoadjuvant chez des patients québécois avec cancer digestifs hauts présentant une instabilité des microsatellites, from 2025-10-18 to 2027-06-30
- Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly diagnosed metastatic pancreatic adenocarcinoma: a feasibility and proof-of-concept study, from 2019-10-01 to 2025-03-31